I must admit I never envisioned these levels .06 to .08.
I must admit I never envisioned these levels .06 to .08. First and foremost I believe the action on Wednesday from .115 to .0669 was done intentionally with malice. As we all know it came out of 1 mm csti approx 7m of the 8.8m sold. Frankly as bad as it was and indeed it was SCRC was able to handle 9m shares of trading and essentially finish at .07 cents. If someone would have said to me that we were going to trade 9m shares frankly although bad at .07 it could have been far worse and much lower. There is no doubt in my mind it was 1 individual who wanted to hurt the company. Well from .11 to .0669 we have already recoverd 50% on what we lost Wednesday. Now oddly enough this has brought more eyes on SCRC mostly scalpers/traders which is fine. I believe most will scalp 10% to 25% and be gone, however a few may look at what they own and decide to actually invest a few shares in SCRC. If we are able to recover to .10 cents in the next several weeks then this move down was worth it because it will bring in more awareness.
There is no question the termination with CVS hurt business and I personally did not see this coming nor did anyone. CVS is a big part of the market roughly 30%. To shed a blind eye to this would be a mistake, however the company can do other things on the expense side to soften the blow. Also if and when a new pharmacy is commenced we will move from 7 states to approx 40 states is my understanding. It will take time to fully ramp up at the new site when it takes place to train a pharmacist and learn the business.remember when we started on at Main Ave it took several months to truly ramp up. This will be no different when it comes and I have strong belief in Bob and his team that we will do very well in the 2nd half of the year. I have no idea what the #s will be but with the additional 33 states and lets say we start that in q3 that will help us out tremendously.
I would like to state that SCRC is a penny stock and often seems to be under a microscope. We should be looking at the macro picture when investing at SCRC. I have no comment on q4 as thats in the rear view mirror now and we all will look at the 10k when its completed and then make comments. The good news that q1 is profitable not an easy task for a penny stock. Yes its probably lower than most would like but I am happy it's in the black. Whatever took place in q4 it seems we have straightened out some issues. The company still expects to be profitable this year and there are things further out that can help us enormously. Rapimeds/dispensing program can be a big lift. I will not put a time-line on either as I want to see how the pilot program takes place at the dispensing program. A new pharmacy can be very enormous especially with the additional 33 states and my expectation is 90 to 120 days out for any meaningful business. Again I have no ideas what the #s will be as I will not put the cart before the horse.
We will survive this latest hit as we are profitable in q1 and will still have cash as well as the 4m L.O.C. Congrats to all the CORE for digging in during this most trying time and Thank you for all your support as well. I know many of the core that bought in at .07 to .09 and I hope your rewarded for your efforts. I see that the "CORE" is recognized now for having 40m shares which is a pretty significant part of the float of approx 85m. We have survived 39 notes, Having no $$$$ for almost 2 years, Ironridge approx 12m shares free trading, losing CVS, and a huge seller on Wednesday. Not only will we survive this there will be a time that we will thrive again as a company as well as a stock. The dream is intact for all and I appreciate all your efforts in bringing the very best to SCRC.
SHOCK AND AWE COMING TO A LOCAL THEATRE
ScripsAmerica Inc (SCRC) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Castings are rarely glamorous until nobody can get them, and Mudrick Capital is betting that ugly little industrial reality could make Doncasters worth far more in a takeover than the market currently credits. The event-driven investor, which says it owns roughly 4.3% of DPC Holdings Limited, has asked the board to quietly evaluate strategic alternatives, including a sale...
Continue Reading
A wealth manager’s website rarely earns applause, but a bad one can sure as hell lose trust fast. Vanguard’s move to No. 1 from No. 3 in the 2025 ranking for advised-investor website satisfaction is worth noticing because it hits the unglamorous part of wealth management that clients actually live with: checking accounts, understanding a plan, moving cash, and...
Continue Reading
Personalized cancer vaccines have no shortage of grand promises; seasoned clinical operators are the rarer commodity. That is why BreakBio's appointment of Dr. Greg Lizée as chief scientific officer deserves a closer look, even if nobody should confuse an executive hire with clinical validation. BreakBio is private, its lead program remains in development, and cancer...
Continue Reading
Two compromised user accounts can turn a supposedly contained cyber problem into a boardroom headache in a hurry. Point72 Asset Management, the global alternative-investment firm founded by Steven A. Cohen in 2014, has reported a social-engineering incident involving accounts that were used to copy files from limited portions of its IT systems. This is not a trading-loss...
Continue Reading
A blister-pack code is doing far more work than it ever should. Green Lumber Holdings is recalling Green Lumber Natural Fuel For Men, lot GL01 with expiration 09/27, after FDA laboratory analysis confirmed undeclared tadalafil in additional samples. The company says the consumer-level recall begins November 19, 2026. This is not a cute labeling nitpick or a marketing...
Continue Reading
One partnership can look like a gold mine from across the valley; getting the ore out is another matter entirely. DarioHealth has struck a strategic partnership with WebMD Health Services that could put its multi-condition care platform in front of an enormous commercial ecosystem: more than 3,500 employers and 65 million covered lives. That is a meaningful distribution...
Continue Reading
A moon mission, a 360-voice choir, and Christmas television make an unusual bundle, but that is precisely why this year’s Tabernacle Choir special has some real staying power. Peace on Earth: Christmas with The Tabernacle Choir is not trying to chase whatever noisy trend is chewing up attention this week. It is building a 90-minute holiday event around Apollo 8,...
Continue Reading
A gold pendant moonlighting as a plot device is not the usual luxury pitch, and thank goodness for that. ACOLT, the Denver-based men's fine jewelry house founded by Colton Hindle, plans an international December 2026 launch of its Gold Collection alongside CHRYSON Volume 1: The Arrival, an original science-fiction comic. The actual hand-forged pieces are meant to show up...
Continue Reading
A returned jacket can turn into a household cash-flow problem faster than retailers seem willing to admit. Seel's new survey lands at an awkward moment for online merchants: shoppers are not merely annoyed by slow refunds; many are budgeting around them. Among 1,921 U.S. adults who had shopped online in the prior six months, 63% said waiting for a retailer to receive a...
Continue Reading
Twenty-one years is a long time to keep a corporate promise from turning into wallpaper. L’Oréal Paris gathered its 2026 Women of Worth class at the Ebell in Los Angeles on November 18, recognizing 10 nonprofit leaders working on problems that do not yield to a glitzy evening or a tidy slogan. That distinction matters. Cancer survivorship, trafficking prevention,...
Continue Reading
Top 5 Most Recently Viewed Articles
February 17, 2026, and the buzz is all about India’s AI landscape—open source is the name of the game. The Linux Foundation just dropped a hefty report claiming India’s AI market will skyrocket from $6 billion in 2024 to nearly $32 billion by 2031. Seriously, that’s some jaw-dropping growth fueled by a mix of homegrown talent, strong government support, and an...
Continue Reading
Understanding the UV LED Market Surge The UV LED market is witnessing a remarkable transformation, with projections indicating it will reach a valuation of USD 2.16 billion by 2030. This trend marks a substantial growth from its anticipated value of USD 1.23 billion in 2025, leading to a compound annual growth rate (CAGR) of 11.9%. Key Factors Driving Market Growth The...
Continue Reading
Revitalizing Three Mile Island with Innovative Solutions Constellation Energy has teamed up with Microsoft (NASDAQ: MSFT) in an exciting partnership aimed at restarting a unit of the Three Mile Island nuclear plant in Pennsylvania. This initiative marks the first attempt to revive a retired nuclear facility, showcasing the changing dynamics in energy solutions. As...
Continue Reading
WideOpenWest, Inc. Under Investigation for Fiduciary Breaches The DJS Law Group has initiated an investigation on behalf of investors regarding WideOpenWest, Inc. (NYSE: WOW). This investigation is focused on potential breaches of fiduciary duty that may have occurred within the company's board of directors and management. The aim is to determine if the directors have...
Continue Reading
Guidehouse Recognized as Celonis Public Sector Partner of the Year Innovation is at the forefront of modern public sector operations, and Guidehouse has made significant strides in this area. The firm was honored with the Celonis Public Sector Partner of the Year award, showcasing its dedication to transforming government processes through advanced technology. Leading...
Continue Reading